SCHEMBL25899692

SCHEMBL25899692

CCc1cc(O)ccc1C(=O)Nc1ccccc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
HTT P42858 1/20 0.49
NPC1 O15118 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
LMNA P02545 2/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
TP53 P04637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
ESR1 P03372 1/20 0.46
ESRRG P62508 1/20 0.46
USP2 O75604 1/20 0.46
POLB P06746 1/20 0.46
PKM P14618 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25899949 0.74 NPC1 (0.56) RAB9AMEN1KMT2AL3MBTL1NPC1
SCHEMBL2701324 0.74 HTT (0.76) RAB9AMEN1KMT2AL3MBTL1HTT
SCHEMBL15463572 0.73 HTT (0.70) RAB9AMEN1KMT2AL3MBTL1HTT
SCHEMBL2700502 0.72 HTT (0.60) RAB9AMEN1KMT2AL3MBTL1HTT
SCHEMBL20059740 0.72 KCNK3 (0.48) MEN1KMT2ALMNAMAPTTP53
SCHEMBL25900021 0.71 SMN1; SMN2 (0.52) RAB9AL3MBTL1HTTNPC1SMN1; SMN2
SCHEMBL2715295 0.71 NPC1 (0.53) RAB9AMEN1KMT2AL3MBTL1HTT
SCHEMBL11699095 0.71 GAA (0.53) RAB9AMEN1KMT2AL3MBTL1HTT
SCHEMBL5163655 0.71 RAB9A (0.48) RAB9AMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL17772176 0.71 HTT (0.63) RAB9AMEN1KMT2AL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4215524-A1 COMPOUND SERVING AS THYROID HORMONE BETA RECEPTOR AGONIST AND USES OF COMPOUND Sunshine Lake Pharma Co., Ltd. (CN) 2023-07-26 EP disclosed